Researchers observed that “cannabis use had a causal effect on lower incidence of renal cell carcinoma.”
Topic: Health/Safety
Investigators concluded, “Incidence of cannabis poisoning or cannabis-related mental or behavioral disorders was low among patients who were authorized to use cannabis for medical care.”
“To our knowledge, this study is one of the first evaluations of the effect of cannabis use on outcomes in patients hospitalized with COVID-19,” authors reported.
Researchers reported that cannabis consumption was associated with improvements in subjects’ sleep, depression/anxiety, and pain.
The most commonly reported indications for medical cannabis use were menopause-related disturbance of sleep and mood/anxiety.
Authors concluded, “Discovery and development of novel antibacterial agents such as CBD are a major step towards the future of therapeutics in a world where antibiotics are no longer efficacious and cost effective.”
Investigators concluded that those with a history of cannabis use had “reduced odds of experiencing 90-day medical complications” following surgery.
Of the nine patients who completed the 12-week trial, six of them reduced their daily consumption of cannabis/tobacco joints by 50 percent.